Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?

Journal of Critical Care

Volumn 23, Issue 4, 2008, Pages 513-518

  Beaulieu, Mathieu ^a   Williamson, David ^a   Sirois, Carole ^a   Lachaine, Jean ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Medical intensive care unit; Nosocomial pneumonia; Proton pump inhibitors

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; PROTON PUMP INHIBITOR; SEDATIVE AGENT;

ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II; ADULT; AGED; ARTICLE; CENTRAL VENOUS CATHETER; DATA BASE; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PNEUMONIA; SCORING SYSTEM;

AGED; APACHE; COHORT STUDIES; CROSS INFECTION; DRUG UTILIZATION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 56949097474     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2007.11.003     Document Type: Article

References (29)

1. Richards M.J., Edwards J.R., Culver D.H., et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27 (1999) 887-892
2. American Thoracic Society, and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
3. Hernandez G., Rico P., Diaz E., et al. Nosocomial lung infections in adult intensive care units. Microbes Infect 6 (2004) 1004-1014
4. Cook D.J., Walter S.D., Cook R.J., et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129 (1998) 433-440
5. Prod'hom G., Leuenberger P., Koerfer J., et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med 120 (1994) 653-662
6. Driks M.R., Craven D.E., Celli B.R., et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization. N Engl J Med 317 (1987) 1376-1382
7. Cook D., Guyatt G., Marshall J., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation: Canadian Critical Care Trials Group. N Engl J Med 338 (1998) 791-797
8. Devlin J.W., Welage L.S., and Olsen K.M. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: clinical efficacy, safety, and economics. Ann Pharmacother 39 (2005) 1844-1851
9. Thorens J., Froehlich F., Schwizer W., et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 39 (1996) 54-59
10. Canani R.B., Cirillo P., Roggero P., et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 117 (2006) e817-e820
11. Laheij R.J., Sturkenboom M.C., Hassing R.J., et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292 (2004) 1955-1960
12. Mallow S., Rebuck J.A., Osler T., et al. Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?. Curr Surg 61 (2004) 452-458
13. Kantorova I., Svoboda P., Scheer P., et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 51 (2004) 757-761
14. Levy M.J., Seelig C.B., Robinson N.J., et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 42 (1997) 1255-1259
15. Conrad S.A., Gabrielli A., Margolis B., et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 33 (2005) 760-765
16. Horan T.C., and Emori T.G. Definitions of key terms used in the NNIS System. Am J Infect Control 25 (1997) 112-116
17. Cook S.F., Visscher W.A., Hobbs C.L., et al. Project IMPACT: results from a pilot validity study of a new observational database. Crit Care Med 30 (2002) 2765-2770
18. Alp E., Guven M., Yildiz O., et al. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann Clin Microbiol Antimicrob 3 (2004) 17
19. Zedtwitz-Liebenstein K., Wenisch C., Patruta S., et al. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 30 (2002) 1118-1122
20. Bell N., Karol M.D., Sachs G., et al. Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers. Aliment Pharmacol Ther 15 (2001) 105-113
21. Laheij R.J., Van Ijzendoorn M.C., Janssen M.J., et al. Gastric acid-suppressive therapy and community-acquired respiratory infections. Aliment Pharmacol Ther 18 (2003) 847-851
22. Gouda B.B., Lydon A.M., Badhe A., et al. A comparison of the effects of ranitidine and omeprazole on volume and pH of gastric contents in elective surgical patients. Eur J Anaesthesiol 21 (2004) 260-264
23. de Jonge E., Schultz M.J., Spanjaard L., et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362 (2003) 1011-1016
24. Huxley E.J., Viroslav J., Gray W.R., et al. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 64 (1978) 564-568
25. Kress J.P., Pohlman A.S., O'Connor M.F., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342 (2000) 1471-1477
26. Rello J., Diaz E., Roque M., et al. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med 159 (1999) 1742-1746
27. Richet H., Hubert B., Nitemberg G., et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 28 (1990) 2520-2525
28. Ibrahim E.H., Tracy L., Hill C., et al. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 120 (2001) 555-561
29. Memish Z.A., Cunningham G., Oni G.A., et al. The incidence and risk factors of ventilator-associated pneumonia in a Riyadh hospital. Infect Control Hosp Epidemiol 21 (2000) 271-273